F C Krugcr. C Daniels, M Kidd. G Swart, K Brundyn, C van Kensburg, M I Kotze Background. Non-alcoholic fatly liver disease (NAFLD) is the most prevalent chronic liver disease in Western countries, but the disease profile has not yet been described in South Africa. NAFLD affects all spheres of society, especially the poorest and least educated.
Aim. To investigate the demographics and clinical and biochemical features of South African patients diagnosed with non-alcoholic fatty liver and non-alcoholic steatohepatitis (NASH) in the Western Cape, South Africa.
Design/method. Overweight/obese subjects were screened by ultrasound and those with fatty liver/hepatomegaly were included. Liver biochemistry, insulin resistance (using the insulin resistance homeostasis model assessment method for insulin resistance, HOMA-1R) and body mass index were assessed and liver biopsies were performed on patients older than 45 years with persistently abnormal liver function and/ or hepatomegaly.
Rcsu/rs. We screened 233 patients: 69% coloured, 25% Caucasian, 5% black and 1% Asian. The majority (73%) were female. NAFLD was confirmed histologically in 111 patients, of whom 36% had NASH and 17% advanced liver fibrosis. No black patient had advanced fibrosis. Subjects with NASH had higher mean triglyceride (p=0.03) and cholesterol (p=0.0T) levels than subjects with NAFL. All patients were insulin resistant/diabetic. HOMA-IR and not the degree of obesity was strongly associated with advanced fibrosis (p=0.09).
Conclusion. This study is the first to describe the clinical characteristics of NAFLD in South Africa, albeit only in the Western Cape population. Insulin resistance was the universal factor present. The degree of obesity was not associated with severity of disease. The role of genetic risk factors in disease development and severity remains to be defined. S Afr Med 12010; 100; 168-171.
Non-alcoholic fatty liver disease (NAFLD) is a complex disorder characterised by histological abnormalities identified on liver biopsy in patients who consume little or no alcohol but present with histological features similar to those seen in alcoholic liver disease. NAFLD is the most prevalent chronic liver disease in Western countries. In the L'SA the estimated prevalence is 17-33%.' Non-alcoholic Steatohepatitis (NASH) is a subset of NAFLD. The estimated prevalence of NASH in the USA is h ;' \ ASH is not a benign liver disease -it may result in increased rates of cirrhosis, hepatocellular carcinoma, liver transplantation and death/ NASH increases in parallel The major risk factors for advanced NAFLD include age 1 -)> • ^i 1 w.H-i. overweight obesitv. insulin re-.isi.inic I.M-II in young, non-obese individuals) and ethnicity." The prevalence of NAFLD/NASH in African Americans appears to be lower than that for other population groups in the L'SA, despite their over-representation of the major risk factors/" h'lhnicity as a major risk factor for NASH has also been highlighted by a postmortem pacdiatric study in the USA showing that there are distinct histopathologic! differences in \AII.I), NASI I between Caucasians and the minority race groups.* African Americ.ins were also ptHtrly represented in this study, again highlighting their low prevalence of NAFLD/NASH. Rthnic differences suggest a role for genetic factors in susceptibility to developing advanced NAFLD, which is supported by family studies. Numerous candidate genes involved in the development and progression of this condition have been investigated.""
ORIGINAL ARTICLES Subjects and methods
The study protocol was approved by the Fthics Review Commiltee of Stellenbosch University, and all patients included signed informed consent.
We included patients who attended the clinics at the Gastroenterology and Hepatology Unit of the Division of Internal Medicine at Tygerberg Hospital and linns Leipoldt and Durbanville Medi-Clinics. Between Julv 2(103 and IX-cember 2006, 233 overweight/obese patients with features suggestive of the metabolic syndrome were screened for hepatic steatosis by ultrasonography.
Sludy design
The following aspects were investigated: gender, age, ethnicity, total cholesterol and triglyceride levels, type 2 diabetes mellitus (DM2). insulin resistance (using the insulin resistance homeostasis model as^'wuenl nielhcxl for insulin resistance, MOMA-1K) and HMI. Known diabetics were excluded from HOMA-IR calculations.
Subjects were grouped according to those who fulfilled the criteria for NASH and NAF L. NAFL is defined as steatosis only or steatosis with inflammation but not fulfilling the criteria for NASH. The subjects with histological features suggestive of another liver disease were excluded. Subjects were also grouped according to the severity of fibrosis: advanced fibrosis (grade 3 and 4) or no/mild fibrosis (grade 0,1 and 2), according to Kleiner cl ttl. a
Biochemical parameters
Liver function, serum glucose, serum insulin and lipograms were determined after an overnight fast, using standard laboratory technique-. Additional blood tests were performed where necessary to exclude other liver diseases. 1IOMA-IR was calculated as follows: fasting glucose « fasting insulin/22.5.
Anthropometric parameters
Height and weight measurements were recorded from which If Mis were calculated as follows: mass in kg/ length in nv\ Liver biopsies Liver biopsies were performed percutaneously under ultrasound guidance, or laparoscope I ly during cholecystectomy for patients with ultrasonographic evidence of steatosis, on patients older than 45 years with tatty infiltration on ultrasound and/or who had persistently abnormal liver function and/or hepatomegaly Histological analysis I iver biopsies were reviewed by the same two pathologists using the criteria of the Nil I Non Alcoholic Steatohepatitis Clinical Research Network (N1H NASH CRN).
-Statistkal analysis
For descriptive purposes, cross-tabulation and frequency tables were used to describe occurrences of various attributes (e.g. gender, ethnicity, etc.) of the sample. Comparisons between different groupings of the sample for measurements (e.g. BMI, I IOMA-IR, etc.) were done using one-way analysis of variance (ANOVA). A 5".. significance level was used ,is guideline for determining significant differences.
Results
The subjects screened were ethnically classified as coloured (69%), Caucasian (25"..), black (5"..) and Asian (I"..). The majority (73"..) of the patients were female.
A total of 182 patients (87"..) had ultrasoni>graphic evidence of fatty infiltration and/or hepatomegaly. Of the group with an ultrasound scan suggesting fatty liver and who fulfilled the criteria for liver biopsy, 127 consented to biopsv. NAI I I) was confirmed in 111 (87%), and of those wilh NAF LD46(36%) had NASH. I ig. la displays histological findings of the group that underwent liver biopsy. Sixtv-three (54"..) of the patients had no histological evidence of fibrosis, while 20 (17"..) had advanced liver fibrosis (stages 3 -4) (Fig. lb) . Fig. 2 illustrates the difference between the males and females affected by NAFl.D with reference to NASH versus NAF L and advanced fibrosis versus no/mild fibrosis. group with advanced fibrosis 57 years (95".. CI 49 -65 years) (/»=0.06). Fig. 4 illustrates the differences between the ethnic groups with regard to presentation with NASH versus NAF I.and grading ol fibrosis. I he Asian population group w.is excluded from the figure, since then was only 1 patient in this group. Table I display?, the mean total cholesterol level (mg/dl), strum triglyceride level (mg/dl), BMI (kg/nv) and HOMA-IR lor each group.
Discussion
We describe the disease profile of NAFLD/NASII for the first time in South African patients in the Western Cape region (heir clinical characteristics are described in terms of histological features and presence of fibrosis, in relation to gender, age, ethnicity, DM2.1IOMA-IK and BMI. Our findings are similar to observations elsewhere in the world."" I lowever, the majority (73%) of our patients were female. Gender was not associated with severity of NAF I.D in this cohort of patients.
Patients were required be 45 years and older to receive a liver biopsy. Although older age was not associated with NASI I, it was associated with more advanced fibrosis. Ethnicity independently was shown to be an important risk factor for advanced disease in the USA/" African American subjects appear to be protected against advanced disease" Our findings suggest the same, despite black patients being under-represented. This warrants further studies to draw comparisons with US studies. Insulin resistance is the common pathogenic factor in the majority of patients with NAF I.D when other causes have been excluded." The subjects not diagnosed with DM2 had a markedly increased mean I IOMA-IK. I his confirms the pathogenic role of insulin resistance in subjects with NAF LD. Even though insulin resistance was not predictive of NASH there was a strong tendency towards predicting advanced fibrosis. DM2 is an independent risk factor for more advanced disease, but our study was unable to demonstrate this." 
